Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 3
1986 1
1987 3
1988 2
1989 3
1990 9
1991 8
1992 9
1993 8
1994 9
1995 8
1996 7
1997 14
1998 14
1999 12
2000 19
2001 18
2002 24
2003 52
2004 54
2005 87
2006 88
2007 114
2008 130
2009 153
2010 192
2011 228
2012 236
2013 325
2014 364
2015 388
2016 461
2017 455
2018 551
2019 569
2020 755
2021 838
2022 607
Text availability
Article attribute
Article type
Publication date

Search Results

6,015 results
Results by year
Filters applied: . Clear all
Page 1
Sequence determinants of human gene regulatory elements.
Sahu B, Hartonen T, Pihlajamaa P, Wei B, Dave K, Zhu F, Kaasinen E, Lidschreiber K, Lidschreiber M, Daub CO, Cramer P, Kivioja T, Taipale J. Sahu B, et al. Among authors: zhu f. Nat Genet. 2022 Mar;54(3):283-294. doi: 10.1038/s41588-021-01009-4. Epub 2022 Feb 21. Nat Genet. 2022. PMID: 35190730 Free PMC article.
Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics.
Liu Q, Zhu F, Liu X, Lu Y, Yao K, Tian N, Tong L, Figge DA, Wang X, Han Y, Li Y, Zhu Y, Hu L, Ji Y, Xu N, Li D, Gu X, Liang R, Gan G, Wu L, Zhang P, Xu T, Hu H, Hu Z, Xu H, Ye D, Yang H, Li B, Tong X. Liu Q, et al. Among authors: zhu f. Nat Metab. 2022 May;4(5):559-574. doi: 10.1038/s42255-022-00575-z. Epub 2022 May 23. Nat Metab. 2022. PMID: 35606596
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials.
Zeng G, Wu Q, Pan H, Li M, Yang J, Wang L, Wu Z, Jiang D, Deng X, Chu K, Zheng W, Wang L, Lu W, Han B, Zhao Y, Zhu F, Yu H, Yin W. Zeng G, et al. Among authors: zhu f. Lancet Infect Dis. 2022 Apr;22(4):483-495. doi: 10.1016/S1473-3099(21)00681-2. Epub 2021 Dec 8. Lancet Infect Dis. 2022. PMID: 34890537 Free PMC article. Clinical Trial.
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.
Halperin SA, Ye L, MacKinnon-Cameron D, Smith B, Cahn PE, Ruiz-Palacios GM, Ikram A, Lanas F, Lourdes Guerrero M, Muñoz Navarro SR, Sued O, Lioznov DA, Dzutseva V, Parveen G, Zhu F, Leppan L, Langley JM, Barreto L, Gou J, Zhu T; CanSino COVID-19 Global Efficacy Study Group. Halperin SA, et al. Among authors: zhu f. Lancet. 2022 Jan 15;399(10321):237-248. doi: 10.1016/S0140-6736(21)02753-7. Epub 2021 Dec 23. Lancet. 2022. PMID: 34953526 Free PMC article. Clinical Trial.
A ten-genes-based diagnostic signature for atherosclerosis.
Zhu F, Zuo L, Hu R, Wang J, Yang Z, Qi X, Feng L. Zhu F, et al. BMC Cardiovasc Disord. 2021 Oct 23;21(1):513. doi: 10.1186/s12872-021-02323-9. BMC Cardiovasc Disord. 2021. PMID: 34688276 Free PMC article.
6,015 results